Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00564525Phase 4Completed
Phase 4, randomised, double-blind trial in functional abdominal pain (FAP) and irritable bowel syndrome (IBS) comparing Placebo with Amitriptyline (2 arms). Primary endpoint: Patient report on whether amitriptyline therapy resulted in adequate relief of symptoms at 5 weeks. Started Oct 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00564525.